V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016162 | 260008308 | 1.84 | 71 | Curative (C) | 2013-09-06 | 2013-09-13 | BEP 3 day | N | N | 260025723 | BEP |
| 260016163 | 260008310 | 1.87 | 101.9 | Curative (C) | null | 2018-01-11 | BEP 5 Day | 2 | N | 260025724 | BEP |
| 260016164 | 260008310 | 1.85 | 57.9 | Palliative (P) | 2015-08-23 | 2015-09-21 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025724 | BENDAMUSTINE + RITUXIMAB |
| 260016165 | 260008312 | 1.57 | 80 | Palliative (P) | 2015-08-17 | 2015-10-04 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 260025728 | BENDAMUSTINE + RITUXIMAB |
| 260016166 | 260008315 | null | null | Curative (C) | 2018-01-24 | 2018-01-25 | BEP 5 Day | 02 | null | 260025733 | BEP |
| 260016167 | 260016666 | 1.74 | 91.5 | Curative (C) | 2014-12-05 | 2015-02-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025734 | BENDAMUSTINE + RITUXIMAB |
| 260016168 | 260008316 | 1.64 | 88.8 | Palliative (P) | 2017-02-10 | 2017-03-07 | BEP 5 Day | 02 | N | 260025735 | BEP |
| 260016169 | 260008321 | 1.75 | 91.7 | Curative (C) | 2016-04-19 | 2016-04-30 | Bendamustine+Rituximab (1st Course) | N | N | 260025738 | BENDAMUSTINE + RITUXIMAB |
| 260016170 | 260008323 | 1.8 | 87 | Palliative (P) | 2017-02-03 | 2017-02-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025741 | BENDAMUSTINE + RITUXIMAB |
| 260016171 | 260008325 | 1.67 | 62 | Disease modification (D) | 2015-10-16 | 2015-12-19 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025742 | BENDAMUSTINE + RITUXIMAB |
| 260016172 | 260008328 | 1.61 | 86 | Palliative (P) | 2014-01-14 | 2014-01-15 | BEP 5 Day | 02 | N | 260025745 | BEP |
| 260016173 | 260008329 | 1.81 | 87 | Palliative (P) | 2016-06-20 | 2016-06-20 | BEP 5 Day | N | N | 260025748 | BEP |
| 260016174 | 260008331 | 1.74 | 82.2 | Curative (C) | 2018-02-08 | 2018-02-11 | BEP 5 Day | N | N | 260025754 | BEP |
| 260016175 | 260008333 | 1.62 | 81 | Palliative (P) | 2016-11-10 | 2016-11-15 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025757 | BENDAMUSTINE + RITUXIMAB |
| 260016176 | 260018013 | 1.69 | 75.3 | Palliative (P) | 2017-06-27 | 2017-09-08 | BEP 3 day | 2 | N | 260025759 | BEP |
| 260016177 | 260008334 | 1.69 | 68.5 | Curative (C) | 2016-08-05 | 2016-08-26 | BEP 5 Day | 02 | N | 260025762 | BEP |
| 260016178 | 260008340 | 1.67 | 97 | Disease modification (D) | 2015-10-15 | 2015-10-26 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025768 | BENDAMUSTINE + RITUXIMAB |
| 260016179 | 260008343 | 1.63 | 69.5 | Palliative (P) | 2015-12-22 | 2016-02-23 | BEP 5 Day | N | N | 260025770 | BEP |
| 260016180 | 260008345 | 1.76 | 158.7 | Curative (C) | null | 2017-03-20 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260025771 | BENDAMUSTINE + RITUXIMAB |
| 260016181 | 260008346 | null | null | null | 2013-09-05 | 2013-10-07 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025774 | BENDAMUSTINE + RITUXIMAB |
| 260016182 | 260008347 | 1.91 | null | Curative (C) | 2017-06-16 | 2017-06-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025775 | BENDAMUSTINE + RITUXIMAB |
| 260016183 | 260008349 | 1.71 | 55 | Curative (C) | 2016-06-07 | 2016-08-14 | BEP 3 day | 02 | N | 260025776 | BEP |
| 260016184 | 260008350 | 1.67 | 77.4 | Neo-adjuvant (N) | 2014-10-31 | 2014-11-15 | BEP 5 Day | N | N | 260025777 | BEP |
| 260016185 | 260008352 | null | null | Curative (C) | 2018-08-22 | 2018-09-10 | BEP 3 day | N | N | 260025778 | BEP |
| 260016186 | 260008354 | 0 | 89.1 | Palliative (P) | 2016-08-09 | 2016-08-18 | BENDAMUSTINE + RITUXIMAB | null | N | 260025782 | BENDAMUSTINE + RITUXIMAB |
| 260016187 | 260008354 | 1.7 | null | Curative (C) | 2016-04-23 | 2016-05-06 | BEP 5 Day | null | N | 260025782 | BEP |
| 260016188 | 260008355 | 1.85 | 72 | Curative (C) | 2016-05-12 | 2016-07-19 | BENDAMUSTINE + RITUXIMAB | N | N | 260025788 | BENDAMUSTINE + RITUXIMAB |
| 260016189 | 260008359 | 1.86 | 73 | null | null | 2014-12-24 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260025800 | BENDAMUSTINE + RITUXIMAB |
| 260016190 | 260008360 | 1.68 | null | Curative (C) | 2017-05-23 | 2017-06-25 | BEP 5 Day | N | N | 260025805 | BEP |
| 260016191 | 260008362 | 1.87 | 94.6 | Neo-adjuvant (N) | 2016-10-21 | 2017-01-03 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260025808 | BENDAMUSTINE + RITUXIMAB |
| 260016192 | 260008363 | 1.78 | 46 | Palliative (P) | 2017-04-06 | 2017-04-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025814 | BENDAMUSTINE + RITUXIMAB |
| 260016193 | 260008364 | null | 64.8 | Curative (C) | 2016-09-08 | 2016-10-25 | BEP 5 Day | N | N | 260025815 | BEP |
| 260016194 | 260008366 | 1.6 | 96.7 | Curative (C) | 2018-03-11 | 2018-03-11 | BEP 5 Day | N | N | 260025816 | BEP |
| 260016195 | 260008367 | 1.67 | 77 | Palliative (P) | 2014-07-29 | 2014-08-15 | BEP 3 day | 02 | N | 260025831 | BEP |
| 260016196 | 260008369 | 1.7 | 77 | Disease modification (D) | 2014-02-15 | 2014-03-08 | Bendamustine+Rituximab(Sub Courses) | N | null | 260025832 | BENDAMUSTINE + RITUXIMAB |
| 260016197 | 260016679 | 1.73 | null | Curative (C) | 2015-10-26 | 2015-11-07 | BEP 3 day | 02 | N | 260025833 | BEP |
| 260016198 | 260018685 | 1.78 | 90.6 | Curative (C) | 2016-12-06 | 2016-12-14 | BEP 3 day | N | N | 260025834 | BEP |
| 260016199 | 260008372 | null | 67.3 | Curative (C) | 2013-06-08 | 2013-07-26 | BENDAMUSTINE + RITUXIMAB | N | null | 260025837 | BENDAMUSTINE + RITUXIMAB |
| 260016200 | 260008373 | 1.77 | 63.4 | Curative (C) | 2017-05-22 | 2017-05-24 | BEP 3 day | N | N | 260025854 | BEP |
| 260016201 | 260008373 | null | null | Palliative (P) | 2015-01-31 | 2015-03-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260025854 | BENDAMUSTINE + RITUXIMAB |
| 260016202 | 260008374 | 1.63 | 90 | Palliative (P) | 2016-12-17 | 2016-12-27 | BEP 5 Day | 02 | N | 260025865 | BEP |
| 260016203 | 260008376 | 1.9 | 64.85 | null | 2017-10-25 | 2017-11-15 | Bendamustine+Rituximab (1st Course) | 02 | N | 260025868 | BENDAMUSTINE + RITUXIMAB |
| 260016204 | 260008377 | 174.5 | null | Palliative (P) | null | 2015-04-26 | BEP 3 day | null | N | 260025872 | BEP |
| 260016205 | 260016683 | 1.93 | 74.8 | Curative (C) | 2015-12-30 | 2016-02-27 | BEP 5 Day | N | N | 260025875 | BEP |
| 260016206 | 260013967 | null | 74.8 | Palliative (P) | 2012-08-16 | 2015-03-21 | BEP 3 day | N | N | 260025881 | BEP |
| 260016207 | 260008384 | 1.81 | 127 | Curative (C) | 2017-03-06 | 2017-03-25 | BENDAMUSTINE + RITUXIMAB | N | N | 260025882 | BENDAMUSTINE + RITUXIMAB |
| 260016208 | 260008385 | 1.76 | 76 | Palliative (P) | 2017-06-01 | 2017-08-30 | BEP 5 Day | 2 | N | 260025887 | BEP |
| 260016209 | 260008387 | 1.89 | null | Palliative (P) | 2018-01-31 | 2018-02-21 | BENDAMUSTINE + RITUXIMAB | N | null | 260025888 | BENDAMUSTINE + RITUXIMAB |
| 260016210 | 260008389 | 1.82 | 59.5 | Curative (C) | 2016-03-10 | 2016-03-10 | BEP 3 day | null | null | 260025889 | BEP |
| 260016211 | 260008391 | null | null | Curative (C) | 2015-01-03 | 2015-01-14 | BENDAMUSTINE + RITUXIMAB | null | null | 260025893 | BENDAMUSTINE + RITUXIMAB |